Trump administration to scrap Part D rebates

The Trump administration Thursday released a proposed rule that would prevent drug companies from paying rebates to PBMs, Medicare Part D plans and Medicaid managed care organizations for drugs purchased by Medicare Part D.

The proposed rule would allow drug companies to provide rebates directly

Read the full 440 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE